English

BITECH PHARMA, INC.

EDGAR

Filing (10KSB) · filed 2006-11-29

1 filing records in this dataset, filed from 2006-11-29 to 2006-11-29. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

6.11 million USD

2006 · USD

Exact inputs and evidence

Revenue: 6114000 USD Source

Operating margin

3.6%

2006 · %

Exact inputs and evidence

Operating Income: 220000 USD Source
Revenue: 6114000 USD Source

Operating cash flow

-1.33 million USD

2006 · USD

Exact inputs and evidence

Operating Cash Flow: -1326000 USD Source

Free cash flow

-1.56 million USD

2006 · USD

Exact inputs and evidence

Operating Cash Flow: -1326000 USD Source
Capital Expenditure: 230000 USD Source

Cash and cash equivalents: 421 thousand USD 2006-06-30 Source
Exact value

421000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-11-29.

Financial data available through: 2006-06-30.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2006-06-30
Operating income: 2 of 11 periods available· newest 2006-06-30
Net income: 2 of 11 periods available· newest 2006-06-30
Operating cash flow: 2 of 11 periods available· newest 2006-06-30
Capital expenditure: 2 of 11 periods available· newest 2006-06-30
Total assets: 2 of 11 periods available· newest 2006-06-30
Total liabilities: 2 of 11 periods available· newest 2006-06-30
Current assets: 2 of 11 periods available· newest 2006-06-30
Current liabilities: 2 of 11 periods available· newest 2006-06-30
Cash and cash equivalents: 2 of 11 periods available· newest 2006-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+55.7%

Prior period

USD 3.93 million

2004-07-01 – 2005-06-30
Current period

USD 6.11 million

2005-07-01 – 2006-06-30

Exact inputs and evidence

6114000 − 3928000 = 2186000 USD

3928000 USD · 2004-07-01 – 2005-06-30
Inspect prior input Prior source
6114000 USD · 2005-07-01 – 2006-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Year-over-year change in Revenue: 2186000 USD Concept: fundies:Revenue Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 6114000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#9525 Input fundies:Revenue: 3928000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#9525
The citation records this snapshot. The page link may show a newer release later.
Net income
-48.4%

Prior period

USD 886,000

2004-07-01 – 2005-06-30
Current period

USD 457,000

2005-07-01 – 2006-06-30

Exact inputs and evidence

457000 − 886000 = -429000 USD

886000 USD · 2004-07-01 – 2005-06-30
Inspect prior input Prior source
457000 USD · 2005-07-01 – 2006-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Year-over-year change in Net income: -429000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 457000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11218 Input fundies:NetIncome: 886000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11218
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-245.6%

Prior period

USD 911,000

2004-07-01 – 2005-06-30
Current period

−USD 1.33 million

2005-07-01 – 2006-06-30

Exact inputs and evidence

-1326000 − 911000 = -2237000 USD

911000 USD · 2004-07-01 – 2005-06-30
Inspect prior input Prior source
-1326000 USD · 2005-07-01 – 2006-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Year-over-year change in Operating cash flow: -2237000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1326000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531 Input fundies:OperatingCashFlow: 911000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-21.2%

Prior period

USD 292,000

2004-07-01 – 2005-06-30
Current period

USD 230,000

2005-07-01 – 2006-06-30

Exact inputs and evidence

230000 − 292000 = -62000 USD

292000 USD · 2004-07-01 – 2005-06-30
Inspect prior input Prior source
230000 USD · 2005-07-01 – 2006-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Year-over-year change in Capital expenditure: -62000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 230000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641 Input fundies:CapitalExpenditure: 292000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2006 2005-07-01 – 2006-06-30

Revenue USD 6.11 million 100% of revenue
Cost of revenue USD 1.69 million 28% of revenue
Operating expenses USD 4.2 million 69% of revenue
Operating income USD 220,000 3.6% of revenue
Tax, interest and other Derived −USD 237,000 −3.9% of revenue
Net income USD 457,000 7.5% of revenue

Cash

Operating cash flow −USD 1.33 million −22% of revenue
Capital expenditure USD 230,000 3.8% of revenue
Free cash flow Derived −USD 1.56 million −25% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 Net income was higher than operating income, so the split is not drawn.
2006 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2004-07-01 – 2005-06-30	3928000	3517000 Derived	411000	-475000 Derived	886000	619000 Derived	Source 2004-07-01 – 2005-06-30: 3928000 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: 411000 USD Inspect Operating Income Open source 2004-07-01 – 2005-06-30: 886000 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: 911000 USD Inspect Operating Cash Flow Open source 2004-07-01 – 2005-06-30: 292000 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	6114000	5894000 Derived	220000	-237000 Derived	457000	-1556000 Derived	Source 2005-07-01 – 2006-06-30: 6114000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: 220000 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: 457000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: -1326000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 230000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 6.1M 2006

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Revenue	3928000	Revenue: 3928000 Open source
20062006-06-30	Revenue	6114000	Revenue: 6114000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

55.7% 2006

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Year over year	No prior comparable period	Revenue: 3928000 Open source
20062006-06-30	Year over year	55.7%	Revenue: 6114000 Open source Revenue: 3928000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.6% 2006

Net margin 7.5% 2006

Free cash flow margin -25.4% 2006

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Operating margin	10.5%	Operating Income: 411000 Open source Revenue: 3928000 Open source
20062006-06-30	Operating margin	3.6%	Operating Income: 220000 Open source Revenue: 6114000 Open source
20052005-06-30	Net margin	22.6%	Net Income: 886000 Open source Revenue: 3928000 Open source
20062006-06-30	Net margin	7.5%	Net Income: 457000 Open source Revenue: 6114000 Open source
20052005-06-30	Free cash flow margin	15.8%	Revenue: 3928000 Open source Operating Cash Flow: 911000 Open source Capital Expenditure: 292000 Open source
20062006-06-30	Free cash flow margin	-25.4%	Revenue: 6114000 Open source Operating Cash Flow: -1326000 Open source Capital Expenditure: 230000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2006

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Operating cash flow	911000	Operating Cash Flow: 911000 Open source
20062006-06-30	Operating cash flow	-1326000	Operating Cash Flow: -1326000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -1.6M 2006

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-06-30	Free cash flow	619000	Operating Cash Flow: 911000 Open source Capital Expenditure: 292000 Open source
20062006-06-30	Free cash flow	-1556000	Operating Cash Flow: -1326000 Open source Capital Expenditure: 230000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.1% 2006

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Liabilities / assets	33.5%	Total Liabilities: 1684000 Open source Total Assets: 5031000 Open source
20062006-06-30	Liabilities / assets	36.1%	Total Liabilities: 2238000 Open source Total Assets: 6206000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.21× 2006

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-06-30	Current assets / current liabilities	2.27×	Current Assets: 3817000 Open source Current Liabilities: 1684000 Open source
20062006-06-30	Current assets / current liabilities	2.21×	Current Assets: 4952000 Open source Current Liabilities: 2238000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2004-07-01 – 2005-06-30	USD 886,000 Exact value Exact value: 886000 USD 2004-07-01 – 2005-06-30: 886000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BITECH PHARMA, INC. · 2005-06-30 BITECH PHARMA, INC. (edgar:1347188) Net Income: 886000 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: 886000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11218 The citation records this snapshot. The page link may show a newer release later.	USD 911,000 Exact value Exact value: 911000 USD 2004-07-01 – 2005-06-30: 911000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BITECH PHARMA, INC. · 2005-06-30 BITECH PHARMA, INC. (edgar:1347188) Operating Cash Flow: 911000 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 911000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531 The citation records this snapshot. The page link may show a newer release later.	USD 292,000 Exact value Exact value: 292000 USD 2004-07-01 – 2005-06-30: 292000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BITECH PHARMA, INC. · 2005-06-30 BITECH PHARMA, INC. (edgar:1347188) Capital Expenditure: 292000 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 292000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641 The citation records this snapshot. The page link may show a newer release later.	USD 619,000 Calculation and evidence 911000 − 292000 USD Exact free cash flow: 619000 USD 2004-07-01 – 2005-06-30: 911000 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 292000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BITECH PHARMA, INC. · 2005-06-30 BITECH PHARMA, INC. (edgar:1347188) Free cash flow: 619000 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 911000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531 Input fundies:CapitalExpenditure: 292000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	USD 457,000 Exact value Exact value: 457000 USD 2005-07-01 – 2006-06-30: 457000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Net Income: 457000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: 457000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11218 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Exact value Exact value: -1326000 USD 2005-07-01 – 2006-06-30: -1326000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Operating Cash Flow: -1326000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1326000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531 The citation records this snapshot. The page link may show a newer release later.	USD 230,000 Exact value Exact value: 230000 USD 2005-07-01 – 2006-06-30: 230000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Capital Expenditure: 230000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 230000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641 The citation records this snapshot. The page link may show a newer release later.	−USD 1.56 million Calculation and evidence -1326000 − 230000 USD Exact free cash flow: -1556000 USD 2005-07-01 – 2006-06-30: -1326000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 230000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BITECH PHARMA, INC. · 2006-06-30 BITECH PHARMA, INC. (edgar:1347188) Free cash flow: -1556000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-04T17:19:59Z Snapshot: 26a60fcabc42573ad5fc37002f5d51473ccef7ab5b7913217fcee5192a51ae4f Dimensions: Consolidated View: https://fundies.io/companies/edgar/1347188?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1326000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11531 Input fundies:CapitalExpenditure: 230000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1347188/0001144204-06-050375.txt#11641 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

1 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001347188, 1347188, edgar:1347188

Also known as CHINA RX HOLDINGS, INC.

BITECH PHARMA, INC.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2006 2005-07-01 – 2006-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation